PUBLISHER: IMARC | PRODUCT CODE: 1541000
PUBLISHER: IMARC | PRODUCT CODE: 1541000
The global apheresis equipment market size reached US$ 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 5.4 Billion by 2032, exhibiting a growth rate (CAGR) of 8% during 2024-2032.
Apheresis equipment is used to remove specific constituents from the blood, such as the cells, plasma, platelets or leukocytes, using either centrifugal or membrane filtration methods. The remaining blood components are then reintroduced into the bloodstream of the donor or patient. It finds application in blood banks and the treatment of various medical conditions. In recent years, the introduction of modern apheresis equipment has led to the development of advanced features, such as auto elutriation and fluid flow dynamics, and has enabled the collection of platelets or red blood cells (RBCs) concentrates.
Due to the spread of the coronavirus disease (COVID-19) and lack of an effective vaccine or treatment, convalescent plasma therapy is emerging as a measure for treating critically ill patients. Apheresis equipment is utilized in this therapy to collect convalescent plasma (CP) from fully recovered patients and transfuse it to active patients as a source of antibodies. Besides this, the growing prevalence of chronic diseases and neurological disorders, along with the rising number of blood donors, is also contributing to the market growth. Moreover, favorable reimbursement policies, coupled with improving healthcare infrastructure, are also driving the sales of apheresis equipment around the world. Other factors, such as the introduction of advanced variants with automated interface systems, screen navigation and graphical user interface displays, along with the increasing investments in research and development (R&D) activities, are expected to create a positive outlook for the market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global apheresis equipment market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application, procedure, technology and end user.
Disposable Apheresis Kits
Apheresis Machine
Blood Collection
Treatment
Neurology
Hematology
Renal Diseases
Others
Plasmapherasis
Plateletpherasis
Erythrocytapheresis
Leukapheresis
Photopheresis
Others
Membrane Filtration
Centrifugation
Blood Collection Centers
Hospitals and Clinics
Others
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Asahi Kasei Corporation, B. Braun Melsungen Aktiengesellschaft, Baxter International Inc., Fresenius Kabi Aktiengesellschaft (Fresenius SE & Co. KGaA), Haemonetics Corporation, Hemacare Corporation (Charles River Laboratories Inc.), Kaneka Corporation, Kawasumi Laboratories Inc., Medica SpA, Nikkiso Co Ltd. and Terumo BCT Inc. (Terumo Corporation).